Novartis NVS announced that the FDA has approved breast cancer drug Kisqali (ribociclib) for a broader population. The ...

Novartis’ Kisqali receives US FDA approval to reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Thursday, September 19, 2024, 13:00 Hrs [IST] Novarti ...

Regulatory reviews for ribociclib among patients with early breast cancer are continuously ongoing to include the EMA and China. 1. FDA approves Kisqali with an aromatase inhibitor and Kisqali Femara ...

During the Quad summit, US President Joe Biden was overheard via a hot mic discussing China's aggressive behavior and Xi Jinping's domestic focus. Although China wasn't directly mentioned in the ...

China launched a 23-tonne research lab module to its newly built space station Tiangong on Sunday 24 July. The lab Wentian, or "Quest for the Heavens", is expected to carry out biological and life ...

China’s residential slump deepened in August, as expectations of a further drop in new-home prices hampered the country’s efforts to cushion the downturn. The value of new-home sales from the ...

Los Angeles health officials announced they are investigating a handful of locally acquired dengue fever cases in the city of ...

Drinking several cups of caffeinated coffee or tea a day may protect against Type 2 diabetes, coronary heart disease and ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Atlantic City's mayor is now the latest elected official in a string of others from the New Jersey beachside gambling ...

regulatory reviews for Kisqali as an EBC treatment are ongoing worldwide, including in the EU and China. Kisqali has been approved as a treatment for metastatic breast cancer (MBC) patients in ...